Fitness classes help elderly Ugandan women fight rising rates of obesity and diabetes
JINJA, Uganda (Reuters) -Wearing floor-length dresses and wrap-around skirts, the group of elderly women giggle and tease each other as they jog in pairs, hand in hand, across a playing field in Kivubuka, a village in eastern Uganda.
The exercise class is part of a project aimed at reducing increasing rates of noncommunicable diseases such as hypertension, diabetes and heart disease and has attracted more than 1,000 people since it began five years ago.
While famine and malnutrition remain major concerns in several African countries, obesity is increasingly on the march, especially among Ugandan women.
Jane Anonyaalaba, a grandmother, is one of those looking to buck the trend. She used to struggle with high blood pressure, persistent aches and occasional paralysis in her limbs.
"I would breathe with difficulty. Climbing a hill was almost impossible," the 70-year-old said.
Now, she bends over double to whack three tennis balls with a cricket bat before running between a set of blue plastic wickets.
A quarter of a century ago, just 4% of Ugandan women were obese, but that figure had more than doubled to 10.4% by 2019, according to the latest available dataset provided by the Global Nutrition Report, which tracks global nutrition.
By comparison, male obesity had risen to just 2.3%.
Weekly fitness clubs like Kivubuka may be a model for a local, low-cost approach to supporting aging communities across Africa, where 17% of adult women and 6.8% of men are obese.
As people lead more urban, sedentary lifestyles, and eat cheaper ultra-processed foods, the continent is becoming more obese, according to the World Health Organization (WHO).
Obesity has brought a corollary rise in deaths: around one-third of Ugandans died from NCDs in 2016, almost double the number in 2000.
"I want to think and believe that there (has been) a change in their lives," said Isaac Imaka, who organises the club on behalf of the Gabula Royal Foundation, a charity established by a Ugandan traditional leader.
"This... is a place where you can come and find a new friend, and just have something to talk about."
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 hours ago
- Yahoo
Morphoceuticals Announces Roger Pomerantz, MD, as Chairman of its Board of Directors
Roger Pomerantz, MD MEDFORD, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Morphoceuticals Inc., a TechBio company pioneering AI-guided electroceuticals for tissue repair and organ regeneration, today announced the appointment of industry veteran Roger Pomerantz, MD, as Chairman of its Board of Directors. Pomerantz joins as an independent director. The company is advancing a novel technology platform, based on the first ever atlas of the bioelectrome - the electrical networks by which cells communicate throughout the body, powered by the movement of ions creating voltage patterns. These electrical networks enable cells to work together to take shape into tissues and organs and allow for previously unexplored therapeutic strategies based on tissue repair and organ regeneration. Pomerantz has led the development of 14 large and small molecule therapies, and a breakthrough microbiome therapeutic, that have all won FDA approval. He currently serves on the Boards of Directors for multiple life sciences companies, including Enlivex Therapeutics, Indaptus Therapeutics, 1E Therapeutics and CollPlant. He was the President, CEO and Chairman of Seres Therapeutics, the first publicly traded microbiome therapeutics company. Pomerantz held senior roles at multiple pharmaceutical companies, including as the Global Head of Infectious Disease at Johnson & Johnson and Head of Licensing and Acquisitions at Merck. He holds a BA in Biochemistry and an MD, both from The Johns Hopkins University. 'Morphoceuticals is building a platform that has the potential to transform human health,' said Pomerantz. 'I am proud to become the Chairman of its Board of Directors and collaborate with a first-rate team toward development of a tool with such enormous power.' 'It is a great honor to bring Roger into our company as we near completion of the toolkit necessary to build the first ever atlas of the bioelectrome,' said Jim Jenson, PhD, CEO of Morphoceuticals. 'With his expert guidance, and the extraordinary foundation laid by Drs. Michael Levin and David Kaplan, we can harness the power of non-neural bioelectric circuits that guide re-growth in the body into a platform technology that can address some of the most intractable healthcare challenges.' Morphoceuticals is building on the groundbreaking work of its co-founders, Michael Levin, Vannevar Bush Professor of Biology in the School of Arts and Sciences, and David Kaplan, Stern Family Endowed Professor of Engineering in the School of Engineering, both of Tufts University, who successfully demonstrated limb regeneration in an African clawed frog, becoming the first to achieve functional limb regeneration in an adult animal of a species that does not naturally regenerate complex limbs in adulthood. The company has secured more than $15 million in seed financings, initially led by Juvenescence and Prime Movers Lab. ABOUT MORPHOCEUTICALS Morphoceuticals is a TechBio company focused on understanding and manipulating the bioelectrome to induce regeneration and treat disease. The bioelectrome is the set of electrical communication networks within the body that bind multi-cellular collectives together for a common purpose, maintaining tissue and organ level integrity and health. We are building an atlas of the bioelectrome using our world-first suite of model systems and proprietary AI techniques. By understanding and manipulating these networks, we aim to rewrite them for the treatment of conditions that are inadequately addressed by existing therapeutic strategies. At Morphoceuticals, we are reprogramming the software of life. For more information visit Media Contact Michael FalconePearl Street Partnersmichael@ A photo accompanying this announcement is available at
Yahoo
9 hours ago
- Yahoo
UN Palestinian refugee staff and doctors fainting from hunger in Gaza, says UNRWA
By Olivia Le Poidevin GENEVA (Reuters) -The head of the U.N. Palestinian Refugee Agency said on Tuesday that its staff, as well as doctors and humanitarian workers, were fainting on duty in Gaza due to hunger and exhaustion. UNRWA said it had received dozens of emergency messages from its staff describing grave conditions and exhaustion in the enclave, where Israel has been fighting a war against Hamas since October, 2023. "No one is spared: caretakers in Gaza are also in need of care. Doctors, nurses, journalists and humanitarians are hungry," UNRWA commissioner General Philippe Lazzarini said in a statement, shared by his spokesperson at a press briefing in Geneva. "Many are now fainting due to hunger and exhaustion while performing their duties: reporting atrocities or alleviating some of the suffering." Lazzarini also criticised a U.S.-backed aid distribution scheme run by the Gaza Humanitarian Foundation that has been supplying aid since late May, when Israel, which controls supplies into Gaza, lifted an 11-week blockade. "The so called 'GHF' distribution scheme is a sadistic death trap. Snipers open fire randomly on crowds as if they are given a licence to kill," Lazzarini said. The GHF uses private U.S. security and logistics companies and largely bypasses a U.N.-led system, that Israel alleges has let Hamas-led militants loot aid shipments intended for civilians. Hamas denies the allegation. More than 1,000 people have been reported killed while trying to receive food aid since the end of May, according to UNRWA estimates, Lazzarini said. The U.N. said on July 15 it had recorded at least 875 killings within the past six weeks at aid points in Gaza run by the GHF and convoys run by other relief groups. The majority of those killed were in the vicinity of GHF sites, while the remaining 201 were killed on the routes of other aid convoys. The Israeli Foreign Ministry, GHF and COGAT, the Israeli military aid coordination agency, were not immediately available for comment. GHF has previously told Reuters that such incidents have not occurred on its sites and accused the U.N. of misinformation, which it denies. Solve the daily Crossword
Yahoo
10 hours ago
- Yahoo
Humana to reduce prior authorization requirements
(Reuters) -Humana said on Tuesday it would eliminate about one-third of prior authorizations for outpatient services by January 1, 2026. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
